Bipolar disorders in DSM-5: Changes and implications for clinical research

Michael J. Ostacher, Mark A Frye, Trisha Suppes

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The focus of this chapter is the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) conceptualization of bipolar disorder and the associated implications for DSM-5 diagnostic and clinical research. In comparison to earlier DSM iterations, there are several fundamental revisions in DSM-5 criteria and nomenclature. First, the diagnosis has moved from the inclusive categories of “Mood Disorders” in DSM-IV/IV TR and “Affective Disorders” in DSM-III (each of which included all depressive and bipolar disorders) to its own stand-alone category, Bipolar and related disorders - distinct from depressive disorders. Second, the fundamental Criterion A for the diagnosis of a manic or hypomanic episode now requires increased energy or activity to be present with elevated, expansive, or irritable mood. Third, mixed episodes - the presence of a concurrent manic and major depressive episode - has been removed and replaced with a “mixed specifier” feature, allowing “mixed” to be used when subsyndromal depressive or manic/hypomanic symptoms are present in the alternate syndromal episodes. Fourth, antidepressant or other treatment-induced full-syndromal mania or hypomania is no longer diagnosed if symptoms persist and meet episode criteria beyond the physiological effects of the drug, essentially allowing all people whose manic symptoms appear during antidepressant treatment and continue despite stopping the antidepressant to be formally diagnosed with bipolar I or II disorder. Finally, an “anxious distress” modifier has been added as anxious symptoms are commonly present in bipolar disorder but are not accounted for in its diagnostic criteria. Short-duration hypomania with depressive episodes was considered as a diagnostic entity and ultimately included in Section III as a condition for further study; it should also be noted that the Not Otherwise Specified (NOS) category is now replaced throughout DSM-5 by Other Specified and an Unspecified category. The Other Specified is intended to identify four distinct bipolar spectrum conditions, including short-duration hypomania with depression. DSM-5 is intended to bridge the gap between the evidence collected in the Research Domain Criteria (RDoC) context - “new ways of classifying mental disorders based on behavioral dimensions and neurobiological measures” - and practice. The National Institute of Mental Health (NIMH)‘s RDoC sets up a framework for the understanding of domains of brain functioning and impairment independent of the current diagnostic structure. It is hoped and anticipated that such work will allow for a better understanding of psychopathology across clinical entities (Insel et al., 2010).

Original languageEnglish (US)
Title of host publicationBipolar Disorders
Subtitle of host publicationBasic Mechanisms and Therapeutic Implications, Third Edition
PublisherCambridge University Press
Pages1-7
Number of pages7
ISBN (Electronic)9781107477278
ISBN (Print)9781107062719
DOIs
StatePublished - Jan 1 2016

Fingerprint

Bipolar Disorder
Diagnostic and Statistical Manual of Mental Disorders
Antidepressive Agents
Depressive Disorder
Mood Disorders
Research
Physiological Effects of Drugs
Irritable Mood
National Institute of Mental Health (U.S.)
Psychopathology
Terminology
Mental Disorders
Depression
Brain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ostacher, M. J., Frye, M. A., & Suppes, T. (2016). Bipolar disorders in DSM-5: Changes and implications for clinical research. In Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition (pp. 1-7). Cambridge University Press. https://doi.org/10.1017/CBO9781107477278.002

Bipolar disorders in DSM-5 : Changes and implications for clinical research. / Ostacher, Michael J.; Frye, Mark A; Suppes, Trisha.

Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition. Cambridge University Press, 2016. p. 1-7.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ostacher, MJ, Frye, MA & Suppes, T 2016, Bipolar disorders in DSM-5: Changes and implications for clinical research. in Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition. Cambridge University Press, pp. 1-7. https://doi.org/10.1017/CBO9781107477278.002
Ostacher MJ, Frye MA, Suppes T. Bipolar disorders in DSM-5: Changes and implications for clinical research. In Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition. Cambridge University Press. 2016. p. 1-7 https://doi.org/10.1017/CBO9781107477278.002
Ostacher, Michael J. ; Frye, Mark A ; Suppes, Trisha. / Bipolar disorders in DSM-5 : Changes and implications for clinical research. Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Third Edition. Cambridge University Press, 2016. pp. 1-7
@inbook{96698df6db6d4fc2a2c173373c78ac6e,
title = "Bipolar disorders in DSM-5: Changes and implications for clinical research",
abstract = "The focus of this chapter is the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) conceptualization of bipolar disorder and the associated implications for DSM-5 diagnostic and clinical research. In comparison to earlier DSM iterations, there are several fundamental revisions in DSM-5 criteria and nomenclature. First, the diagnosis has moved from the inclusive categories of “Mood Disorders” in DSM-IV/IV TR and “Affective Disorders” in DSM-III (each of which included all depressive and bipolar disorders) to its own stand-alone category, Bipolar and related disorders - distinct from depressive disorders. Second, the fundamental Criterion A for the diagnosis of a manic or hypomanic episode now requires increased energy or activity to be present with elevated, expansive, or irritable mood. Third, mixed episodes - the presence of a concurrent manic and major depressive episode - has been removed and replaced with a “mixed specifier” feature, allowing “mixed” to be used when subsyndromal depressive or manic/hypomanic symptoms are present in the alternate syndromal episodes. Fourth, antidepressant or other treatment-induced full-syndromal mania or hypomania is no longer diagnosed if symptoms persist and meet episode criteria beyond the physiological effects of the drug, essentially allowing all people whose manic symptoms appear during antidepressant treatment and continue despite stopping the antidepressant to be formally diagnosed with bipolar I or II disorder. Finally, an “anxious distress” modifier has been added as anxious symptoms are commonly present in bipolar disorder but are not accounted for in its diagnostic criteria. Short-duration hypomania with depressive episodes was considered as a diagnostic entity and ultimately included in Section III as a condition for further study; it should also be noted that the Not Otherwise Specified (NOS) category is now replaced throughout DSM-5 by Other Specified and an Unspecified category. The Other Specified is intended to identify four distinct bipolar spectrum conditions, including short-duration hypomania with depression. DSM-5 is intended to bridge the gap between the evidence collected in the Research Domain Criteria (RDoC) context - “new ways of classifying mental disorders based on behavioral dimensions and neurobiological measures” - and practice. The National Institute of Mental Health (NIMH)‘s RDoC sets up a framework for the understanding of domains of brain functioning and impairment independent of the current diagnostic structure. It is hoped and anticipated that such work will allow for a better understanding of psychopathology across clinical entities (Insel et al., 2010).",
author = "Ostacher, {Michael J.} and Frye, {Mark A} and Trisha Suppes",
year = "2016",
month = "1",
day = "1",
doi = "10.1017/CBO9781107477278.002",
language = "English (US)",
isbn = "9781107062719",
pages = "1--7",
booktitle = "Bipolar Disorders",
publisher = "Cambridge University Press",
address = "United States",

}

TY - CHAP

T1 - Bipolar disorders in DSM-5

T2 - Changes and implications for clinical research

AU - Ostacher, Michael J.

AU - Frye, Mark A

AU - Suppes, Trisha

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The focus of this chapter is the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) conceptualization of bipolar disorder and the associated implications for DSM-5 diagnostic and clinical research. In comparison to earlier DSM iterations, there are several fundamental revisions in DSM-5 criteria and nomenclature. First, the diagnosis has moved from the inclusive categories of “Mood Disorders” in DSM-IV/IV TR and “Affective Disorders” in DSM-III (each of which included all depressive and bipolar disorders) to its own stand-alone category, Bipolar and related disorders - distinct from depressive disorders. Second, the fundamental Criterion A for the diagnosis of a manic or hypomanic episode now requires increased energy or activity to be present with elevated, expansive, or irritable mood. Third, mixed episodes - the presence of a concurrent manic and major depressive episode - has been removed and replaced with a “mixed specifier” feature, allowing “mixed” to be used when subsyndromal depressive or manic/hypomanic symptoms are present in the alternate syndromal episodes. Fourth, antidepressant or other treatment-induced full-syndromal mania or hypomania is no longer diagnosed if symptoms persist and meet episode criteria beyond the physiological effects of the drug, essentially allowing all people whose manic symptoms appear during antidepressant treatment and continue despite stopping the antidepressant to be formally diagnosed with bipolar I or II disorder. Finally, an “anxious distress” modifier has been added as anxious symptoms are commonly present in bipolar disorder but are not accounted for in its diagnostic criteria. Short-duration hypomania with depressive episodes was considered as a diagnostic entity and ultimately included in Section III as a condition for further study; it should also be noted that the Not Otherwise Specified (NOS) category is now replaced throughout DSM-5 by Other Specified and an Unspecified category. The Other Specified is intended to identify four distinct bipolar spectrum conditions, including short-duration hypomania with depression. DSM-5 is intended to bridge the gap between the evidence collected in the Research Domain Criteria (RDoC) context - “new ways of classifying mental disorders based on behavioral dimensions and neurobiological measures” - and practice. The National Institute of Mental Health (NIMH)‘s RDoC sets up a framework for the understanding of domains of brain functioning and impairment independent of the current diagnostic structure. It is hoped and anticipated that such work will allow for a better understanding of psychopathology across clinical entities (Insel et al., 2010).

AB - The focus of this chapter is the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) conceptualization of bipolar disorder and the associated implications for DSM-5 diagnostic and clinical research. In comparison to earlier DSM iterations, there are several fundamental revisions in DSM-5 criteria and nomenclature. First, the diagnosis has moved from the inclusive categories of “Mood Disorders” in DSM-IV/IV TR and “Affective Disorders” in DSM-III (each of which included all depressive and bipolar disorders) to its own stand-alone category, Bipolar and related disorders - distinct from depressive disorders. Second, the fundamental Criterion A for the diagnosis of a manic or hypomanic episode now requires increased energy or activity to be present with elevated, expansive, or irritable mood. Third, mixed episodes - the presence of a concurrent manic and major depressive episode - has been removed and replaced with a “mixed specifier” feature, allowing “mixed” to be used when subsyndromal depressive or manic/hypomanic symptoms are present in the alternate syndromal episodes. Fourth, antidepressant or other treatment-induced full-syndromal mania or hypomania is no longer diagnosed if symptoms persist and meet episode criteria beyond the physiological effects of the drug, essentially allowing all people whose manic symptoms appear during antidepressant treatment and continue despite stopping the antidepressant to be formally diagnosed with bipolar I or II disorder. Finally, an “anxious distress” modifier has been added as anxious symptoms are commonly present in bipolar disorder but are not accounted for in its diagnostic criteria. Short-duration hypomania with depressive episodes was considered as a diagnostic entity and ultimately included in Section III as a condition for further study; it should also be noted that the Not Otherwise Specified (NOS) category is now replaced throughout DSM-5 by Other Specified and an Unspecified category. The Other Specified is intended to identify four distinct bipolar spectrum conditions, including short-duration hypomania with depression. DSM-5 is intended to bridge the gap between the evidence collected in the Research Domain Criteria (RDoC) context - “new ways of classifying mental disorders based on behavioral dimensions and neurobiological measures” - and practice. The National Institute of Mental Health (NIMH)‘s RDoC sets up a framework for the understanding of domains of brain functioning and impairment independent of the current diagnostic structure. It is hoped and anticipated that such work will allow for a better understanding of psychopathology across clinical entities (Insel et al., 2010).

UR - http://www.scopus.com/inward/record.url?scp=85021988811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021988811&partnerID=8YFLogxK

U2 - 10.1017/CBO9781107477278.002

DO - 10.1017/CBO9781107477278.002

M3 - Chapter

AN - SCOPUS:85021988811

SN - 9781107062719

SP - 1

EP - 7

BT - Bipolar Disorders

PB - Cambridge University Press

ER -